✦ LIBER ✦

Analysis ofCYP7B1in non-consanguineous cases of hereditary spastic paraplegia

✍ Scribed by Rebecca Schüle; Elisabeth Brandt; Kathrin N. Karle; Maria Tsaousidou; Stephan Klebe; Sven Klimpe; Michaela Auer-Grumbach; Andrew H. Crosby; Christian A. Hübner; Ludger Schöls; Thomas Deufel; Christian Beetz

Publisher: Springer
Year: 2008
Tongue: English
Weight: 203 KB
Volume: 10
Category: Article
ISSN: 1364-6745
DOI: 10.1007/s10048-008-0158-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel mutations in the CYP7B1 gene cause

Novel mutations in the CYP7B1 gene cause hereditary spastic paraplegia

✍ Li Cao; Qing-Zhou Fei; Wei-Guo Tang; Jian-Rong Liu; Lan Zheng; Qin Xiao; Song-Bi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 695 KB

Gait analysis of sporadic and hereditary

Gait analysis of sporadic and hereditary spastic paraplegia

✍ S. Klebe; H. Stolze; F. Kopper; D. Lorenz; R. Wenzelburger; J. Volkmann; H. Pors 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 335 KB

An autopsy case of adult-onset hereditar

An autopsy case of adult-onset hereditary spastic paraplegia type 2 with a novel mutation in exon 7 of the proteolipid protein 1 gene

✍ Satoshi O. Suzuki; Toru Iwaki; Kenji Arakawa; Hirokazu Furuya; Naoki Fujii; Akik 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 677 KB

Autosomal dominant hereditary spastic pa

Autosomal dominant hereditary spastic paraplegia: DHPLC-based mutation analysis of SPG4 reveals eleven novel mutations

✍ Clarice Patrono; Valentina Scarano; Federica Cricchi; Mariarosa A. B. Melone; Ma 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

We set up a new denaturing high-performance liquid chromatography (DHPLC)-based protocol to screen patients with autosomal dominant hereditary spastic paraplegia (AD-HSP) for mutations in SPG4. Six patients had a complicated form and 49 a pure HSP phenotype. We also analyzed 19 unrelated patients pr

Botulinum neurotoxin type A injections r

Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia— Report of 19 cases

✍ Martin J. Hecht; Henning Stolze; Matthias Auf Dem Brinke; Ralf Giess; Thoams Tre 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

## Abstract Hereditary spastic paraplegia (HSP) is characterized by lower extremity spasticity. Symptomatic therapy generally includes physical therapy and oral antispastic agents, in selected cases intrathecal baclofen. Because of the positive results in other treatments of spasticity, the use of

Mutation analysis of the spastin gene (S

Mutation analysis of the spastin gene (SPG4) in patients in Germany with autosomal dominant hereditary spastic paraplegia

✍ S. Sauter; B. Miterski; S. Klimpe; D. Bönsch; L. Schöls; A. Visbeck; T. Papke; H 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views

Hereditary spastic paraplegias (HSP) comprise a genetically and clinically heterogeneous group of neurodegenerative disorders characterized by progressive spasticity and hyperreflexia of the lower limbs. Autosomal dominant hereditary spastic paraplegia 4 linked to chromosome 2p (SPG4) is the most co